{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:21:47Z","timestamp":1783948907588,"version":"3.55.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1038\/s41433-024-03403-8","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T03:08:15Z","timestamp":1729480095000},"page":"175-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease\u2014a prospective pilot study"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9995-8574","authenticated-orcid":false,"given":"Roee","family":"Arnon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-1066","authenticated-orcid":false,"given":"Hila","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3967-2694","authenticated-orcid":false,"given":"Guy J.","family":"Ben-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayelet","family":"Priel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-424X","authenticated-orcid":false,"given":"Ofira","family":"Zloto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0910-3829","authenticated-orcid":false,"given":"Daphna","family":"Landau-Prat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Cukierman-Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0563-278X","authenticated-orcid":false,"given":"Oded","family":"Sagiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"3403_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/ceo.13899","volume":"49","author":"AP Jain","year":"2021","unstructured":"Jain AP, Jaru-Ampornpan P, Douglas RS. Thyroid eye disease: redefining its management\u2014a review. Clin Exp Ophthalmol. 2021;49:203\u201311.","journal-title":"Clin Exp Ophthalmol."},{"key":"3403_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/bjophthalmol-2018-313578","volume":"104","author":"DC Lee","year":"2020","unstructured":"Lee DC, Young SM, Kim YD, Woo KI. Course of upper eyelid retraction in thyroid eye disease. Br J Ophthalmol. 2020;104:254\u20139.","journal-title":"Br J Ophthalmol"},{"key":"3403_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1097\/IOP.0000000000001122","volume":"34","author":"JJ Dutton","year":"2018","unstructured":"Dutton JJ. Anatomic considerations in thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2018;34:S7\u201312.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3403_CR4","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves\u2019 Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol. 2021;185:G43\u201367.","journal-title":"Eur J Endocrinol"},{"key":"3403_CR5","first-page":"181","volume":"9","author":"H Lepor","year":"2007","unstructured":"Lepor H. Alpha blockers for the treatment of benign prostatic hyperplasia. Rev Urol. 2007;9:181.","journal-title":"Rev Urol."},{"key":"3403_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/0253-7613.178825","volume":"48","author":"R Manjunatha","year":"2016","unstructured":"Manjunatha R, Pundarikaksha HP, Madhusudhana HR, Amarkumar J, Hanumantharaju BK. A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia. Indian J Pharmacol. 2016;48:134.","journal-title":"Indian J Pharmacol."},{"key":"3403_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s40264-018-0674-y","volume":"41","author":"SA Kaplan","year":"2018","unstructured":"Kaplan SA, Chughtai BI. Safety of tamsulosin: a systematic review of randomized trials with a focus on women and children. Drug Saf. 2018;41:835\u201342.","journal-title":"Drug Saf."},{"key":"3403_CR8","doi-asserted-by":"crossref","unstructured":"Leshno A, Smadar L, Kapelushnik N, Serlin T, Prat D, Priel A, et al. New insight into the physiologic function of M\u00fcller\u2019s muscle. Exp Eye Res. 2021;202:108336.","DOI":"10.1016\/j.exer.2020.108336"},{"key":"3403_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/01.ico.0000148312.01805.53","volume":"24","author":"F R\u00fcfer","year":"2005","unstructured":"R\u00fcfer F, Schr\u00f6der A, Erb C. White-to-white corneal diameter: normal values in healthy humans obtained with the Orbscan II topography system. Cornea 2005;24:259\u201361.","journal-title":"Cornea"},{"key":"3403_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1097\/IOP.0b013e3182523b7f","volume":"28","author":"AM Putterman","year":"2012","unstructured":"Putterman AM. Margin reflex distance (MRD) 1, 2, and 3. Ophthalmic Plast Reconstr Surg. 2012;28:308\u201311.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3403_CR11","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2011.11.001","volume":"26","author":"WM Wiersinga","year":"2012","unstructured":"Wiersinga WM. Quality of life in Graves\u2019 ophthalmopathy. Best Pract Res Clin Endocrinol Metab. 2012;26:359\u201370.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"3403_CR12","doi-asserted-by":"publisher","first-page":"E4287","DOI":"10.1097\/GOX.0000000000004287","volume":"10","author":"BA Simmons","year":"2022","unstructured":"Simmons BA, Tran C, Pham CM, Shriver EM. The effect of teprotumumab on eyelid position in patients with thyroid eye disease. Plast Reconstr Surg Glob Open. 2022;10:E4287.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"3403_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","volume":"20","author":"KE Morgenstern","year":"2004","unstructured":"Morgenstern KE, Evanchan J, Foster JA, Cahill KV, Burns JA, Holck DE, et al. Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthalmic Plast Reconstr Surg. 2004;20:181\u20135.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3403_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IOP.0b013e3181c2a16d","volume":"27","author":"R Mancini","year":"2011","unstructured":"Mancini R, Khadavi NM, Goldberg RA. Nonsurgical management of upper eyelid margin asymmetry using hyaluronic acid gel filler. Ophthalmic Plast Reconstr Surg. 2011;27:1\u20133.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3403_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/tjo.tjo_57_21","volume":"12","author":"T Osaki","year":"2022","unstructured":"Osaki T, Monteiro L, Osaki M. Management of eyelid retraction related to thyroid eye disease. Taiwan J Ophthalmol. 2022;12:12.","journal-title":"Taiwan J Ophthalmol"},{"key":"3403_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","volume":"34","author":"SM Young","year":"2018","unstructured":"Young SM, Kim YD, Lang SS, Woo KI. Transconjunctival triamcinolone injection for upper lid retraction in thyroid eye disease-a new injection method. Ophthalmic Plast Reconstr Surg. 2018;34:587\u201393.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3403_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jcjo.2011.12.005","volume":"47","author":"D Xu","year":"2012","unstructured":"Xu D, Liu Y, Xu H, Li H. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Can J Ophthalmol. 2012;47:34\u201341.","journal-title":"Can J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03403-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03403-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T20:11:50Z","timestamp":1736885510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-03403-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3403"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-03403-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}